CSBR: Champions Oncology Narx-foyda va o‘sish multiplikatori

Champions Oncology Corp (CSBR) brendining ramzi va logotipi

Champions Oncology PDX modellari orqali shaxsiylashtirilgan terapiyani ishlab chiqadi, garchi global mojarolar va savdo to'siqlari vaqti-vaqti bilan biomateriallarning transchegaraviy logistikasini murakkablashtirsa-da. P/E koeffitsiyentining o'sish sur'atiga nisbati tarixi aktivning bozor qiymatini ko'rsatadi, bunda 0.00 ushbu parametrning miqdorini aks ettiradi. Shu bilan birga, AQShda tibbiyotning gumanitar maqomi siyosiy bosimni minimallashtirib, barqaror moliyaviy fonni ta'minlaydi.

Narxning foydaga va o‘sish sur’atiga nisbati: Champions Oncology Inc (CSBR) 04.07.2022 - 15.11.2026 uchun

Champions Oncology Inc (CSBR) kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:Champions Oncology Corp, CSBR
Champions Oncology, Inc. seriyali mahsuloti

Geopolitik beqarorlik va savdo to'siqlari Champions Oncology (CSBR) uchun biomateriallarning transchegaraviy logistikasini murakkablashtirib, kengayish sur'atlari uchun xavflarni keltirib chiqarmoqda. Ushbu jarayonlarni baholash uchun daromad o'sish sur'atlariga nisbatan P/E koeffitsiyenti ishlatiladi. Birga solishtirganda birdan past qiymat aktivning o'sish dinamikasiga nisbatan qadrsizlanganligini anglatadi. Ushbu usul uzoq muddatli investitsiyalarda xavf va daromadning samarali muvozanatini ta'minlash imkonini beradi. Nisbiy qadrsizlanganlikni aniqlash uchun PEG koeffitsiyentini tahlil qilish orqali investor aksiyaning o'sish potentsialini zudlik bilan aniqlashi mumkin.

Raqobatdosh kompaniyalar

Narx-foyda va o‘sish multiplikatori BeiGene Ltd ONC|PEG multiplikatori HALO (halozyme.com)|RVMD - Narx-foyda va o‘sish multiplikatori|AAPG: Narx-foyda va o‘sish multiplikatori|CGON - PEG multiplikatori|UroGen (URGN) - Narxning foydaga va o‘sish sur’atiga nisbati|Bicara Bio - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PSNL (Personalis Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Erasca, Inc. ERAS|PEG multiplikatori DCTH|YMAB - O‘sish sur’atiga tuzatilgan narx-foyda|Aura Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Candel Therapeutics CADL|accuray.com - PEG multiplikatori|SLS: Narxning foydaga va o‘sish sur’atiga nisbati|ACTU (actuatetherapeutics.com) - Narx-foyda va o‘sish multiplikatori|CTOR - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati tuhurabio.com|PEG multiplikatori Protara Tx|Narx-foyda va o‘sish multiplikatori FATE (Fate Therapeutics Corp)|Narxning foydaga va o‘sish sur’atiga nisbati WHWK (Aadi Bioscience)|TScan Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|XBIT - Narx-foyda va o‘sish multiplikatori|CEL-SCI - PEG multiplikatori|OSTX - PEG multiplikatori|Radiopharm Theranostics Limited (RADX) - Narxning foydaga va o‘sish sur’atiga nisbati|ARTV - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ANL|Narxning foydaga va o‘sish sur’atiga nisbati VERU|PEG multiplikatori TPST|XLO: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori RENB (Renovaro Inc.)|Mural Bio (MURA) - O‘sish sur’atiga tuzatilgan narx-foyda|Kairos Pharma Ltd - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati OKUR|CytoMed Therapeutics Limited (GDTC) - Narxning foydaga va o‘sish sur’atiga nisbati|CRIS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori APLM|Tharimmune (THAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ADVB (Advanced Biomed Inc.)|Genprex - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Narx-foyda va o‘sish multiplikatori|Xenetic Bio - PEG multiplikatori|SLRX - PEG multiplikatori|PPBT: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti AONC|BGNE (BeiGene Ltd) - PEG multiplikatori|CKPT (Checkpoint Therapeutics, Inc) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ELEV|Narx-foyda va o‘sish multiplikatori iCAD Corp ICAD|Narxning foydaga va o‘sish sur’atiga nisbati ikenaoncology.com IKNA|NTBL - Narx-foyda va o‘sish multiplikatori|VIRX - Narxning foydaga va o‘sish sur’atiga nisbati|MOR - PEG multiplikatori|NAYA: PEG multiplikatori|Ascentage Pharma Group (AAPGV) - PEG multiplikatori